New insights into the molecular regulation of mechanotransduction
Project Number1DP2GM149549-01
Former Number1DP2OD032876-01
Contact PI/Project LeaderCASE, LINDSAY
Awardee OrganizationMASSACHUSETTS INSTITUTE OF TECHNOLOGY
Description
Abstract Text
Project summary
Cells exist in a physical world, and there is often a physical basis for human function and disease.
Mechanotransduction is the molecular process by which cells sense and respond to mechanical signals in their
environment. Abnormal mechanotransduction can contribute to many human diseases including asthma, heart
failure, osteoporosis, and cancer. Thus, it is crucial to understand the molecular basis of mechanotransduction
and how these signaling pathways are disrupted during disease. Integrin receptors are critical regulators of
mechanotransduction at the plasma membrane that signal through the assembly supramolecular complexes
termed “focal adhesions.” Focal adhesions physically connect the actin cytoskeleton to the extracellular
environment, and forces generated in the actin cytoskeleton are transmitted across focal adhesions to drive
tissue morphogenesis, cell movement, and extracellular matrix remodeling. Although the proper regulation of
focal adhesions is essential for integrin-dependent mechanotransduction, important questions about their
formation and function remain unanswered. We do not understand how focal adhesions form, how they grow, or
how their molecular composition is regulated. Cell-based experiments have led to conflicting observations, and
we have limited tools to understand how changing molecular composition can create focal adhesions with
specific chemical or physical characteristics that alter downstream signaling.
To address these important questions, Dr. Case has developed a novel biochemical reconstitution of
focal adhesions using purified proteins on supported lipid bilayers. This work identified seven proteins that are
sufficient to form focal adhesions through liquid-liquid phase separation. Studying integrin-dependent
mechanotransduction through the lens of phase separation could drive significant advances in the field. The
Case Lab will use a variety of experimental strategies to understand different aspects of integrin-dependent
mechanotransduction. They will directly test different models of mechanotransduction with biochemical
reconstitution and confirm the importance of any new in vitro observations with cell-based assays. They will
investigate how focal adhesions mature, how forces are transmitted across focal adhesions, and how the
biochemical composition of focal adhesions is regulated. This project will take advantage of a novel experimental
approach to challenge the current dogma about integrin-dependent mechanotransduction, and will reveal how
specific molecules regulate focal adhesion growth and composition.
Public Health Relevance Statement
Project Narrative
Mechanotransduction is the molecular process by which cells sense and respond to mechanical signals in their
environment. The proposed work will use a new experimental platform to dissect the molecular interactions that
regulate mechanotransduction in adult physiology and disease. Using a novel experimental approach to
challenge the current dogma about the molecular basis of mechanotransduction, we will gain important insight
into how these pathways are disrupted in human disease, including cardiovascular disease.
No Sub Projects information available for 1DP2GM149549-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1DP2GM149549-01
Patents
No Patents information available for 1DP2GM149549-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1DP2GM149549-01
Clinical Studies
No Clinical Studies information available for 1DP2GM149549-01
News and More
Related News Releases
No news release information available for 1DP2GM149549-01
History
No Historical information available for 1DP2GM149549-01
Similar Projects
No Similar Projects information available for 1DP2GM149549-01